Abstract
Objective To explore the expression of c-cbl gene in acute non-lymphocytic leukemia (ANLL) cells and its clinical significance. Methods The mRNA level of c-cbl gene in 47 ANLL adult patients were measured by reverse transcription polymerase chain reaction(RT-PCR). 20 healthy adults were selected as normal controls (NC). Results The mRNA level of c-cbl gene in ANLL patients was significantly lower than in NC. The CR rate of patients with c-cbl negative was lower than that of patients with c cbl positive (P<0.05). Conclusion Over-expression of c-cbl gene may play a synergic role in the pathogenesis of ANLL and associates with CR rate in ANLL. It seems that low expression of c-cbl gene may be used as a marker of poor prognosis in acute non-lymphocytic leukemia. Key words: ubiquitin-protein ligases; c-cbl gene; acute non-lymphocytic leukemia
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Blood Transfusion and Hematology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
